Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 7.27
(-0.27%)
CNY 7.27
(-0.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.77 Billion CNY | 15.13% |
| 2022 | 6.75 Billion CNY | 3.53% |
| 2021 | 6.52 Billion CNY | 12.35% |
| 2020 | 5.8 Billion CNY | 8.47% |
| 2019 | 5.34 Billion CNY | -2.08% |
| 2018 | 5.46 Billion CNY | 14.95% |
| 2017 | 4.75 Billion CNY | 1.66% |
| 2016 | 4.67 Billion CNY | 23.41% |
| 2015 | 3.78 Billion CNY | 28.14% |
| 2014 | 2.95 Billion CNY | 9.72% |
| 2013 | 2.69 Billion CNY | 13.21% |
| 2012 | 2.38 Billion CNY | 0.12% |
| 2011 | 2.37 Billion CNY | 8.74% |
| 2010 | 2.18 Billion CNY | -2.89% |
| 2009 | 2.25 Billion CNY | 3.69% |
| 2008 | 2.17 Billion CNY | -4.31% |
| 2007 | 2.26 Billion CNY | 15.35% |
| 2006 | 1.96 Billion CNY | 4.36% |
| 2005 | 1.88 Billion CNY | 4.36% |
| 2004 | 1.8 Billion CNY | 0.62% |
| 2003 | 1.79 Billion CNY | 14.45% |
| 2002 | 1.56 Billion CNY | 7.69% |
| 2001 | 1.45 Billion CNY | -0.86% |
| 2000 | 1.46 Billion CNY | -1.89% |
| 1999 | 1.49 Billion CNY | 27.04% |
| 1998 | 1.17 Billion CNY | 34.71% |
| 1997 | 875.02 Million CNY | 76.45% |
| 1996 | 495.91 Million CNY | 51.44% |
| 1995 | 327.47 Million CNY | 22.87% |
| 1994 | 266.51 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 7.89 Billion CNY | 1.63% |
| 2024 Q3 | 7.12 Billion CNY | 1.14% |
| 2024 Q2 | 7.04 Billion CNY | -10.81% |
| 2023 FY | 7.77 Billion CNY | 15.13% |
| 2023 Q2 | 6.84 Billion CNY | -2.23% |
| 2023 Q4 | 7.77 Billion CNY | 7.88% |
| 2023 Q3 | 7.2 Billion CNY | 5.29% |
| 2023 Q1 | 6.99 Billion CNY | 3.67% |
| 2022 Q2 | 6.91 Billion CNY | -5.35% |
| 2022 FY | 6.75 Billion CNY | 3.53% |
| 2022 Q4 | 6.75 Billion CNY | -1.96% |
| 2022 Q1 | 7.3 Billion CNY | 12.02% |
| 2022 Q3 | 6.88 Billion CNY | -0.4% |
| 2021 FY | 6.52 Billion CNY | 12.35% |
| 2021 Q1 | 6.13 Billion CNY | 5.66% |
| 2021 Q2 | 6.02 Billion CNY | -1.81% |
| 2021 Q4 | 6.52 Billion CNY | 3.36% |
| 2021 Q3 | 6.3 Billion CNY | 4.78% |
| 2020 FY | 5.8 Billion CNY | 8.47% |
| 2020 Q3 | 5.49 Billion CNY | -3.14% |
| 2020 Q1 | 5.83 Billion CNY | 9.1% |
| 2020 Q2 | 5.67 Billion CNY | -2.75% |
| 2020 Q4 | 5.8 Billion CNY | 5.56% |
| 2019 FY | 5.34 Billion CNY | -2.08% |
| 2019 Q4 | 5.34 Billion CNY | 0.18% |
| 2019 Q1 | 6 Billion CNY | 9.94% |
| 2019 Q2 | 5.64 Billion CNY | -5.99% |
| 2019 Q3 | 5.34 Billion CNY | -5.43% |
| 2018 Q2 | 5.46 Billion CNY | 8.45% |
| 2018 Q1 | 5.03 Billion CNY | 6.04% |
| 2018 Q4 | 5.46 Billion CNY | -0.43% |
| 2018 FY | 5.46 Billion CNY | 14.95% |
| 2018 Q3 | 5.48 Billion CNY | 0.39% |
| 2017 Q2 | 4.75 Billion CNY | -0.0% |
| 2017 Q3 | 4.85 Billion CNY | 1.95% |
| 2017 Q1 | 4.75 Billion CNY | 1.8% |
| 2017 Q4 | 4.75 Billion CNY | -2.05% |
| 2017 FY | 4.75 Billion CNY | 1.66% |
| 2016 Q3 | 4.62 Billion CNY | 17.09% |
| 2016 Q1 | 3.94 Billion CNY | 4.08% |
| 2016 Q2 | 3.94 Billion CNY | 0.16% |
| 2016 Q4 | 4.67 Billion CNY | 1.11% |
| 2016 FY | 4.67 Billion CNY | 23.41% |
| 2015 Q4 | 3.78 Billion CNY | 11.09% |
| 2015 Q2 | 3.12 Billion CNY | 1.84% |
| 2015 FY | 3.78 Billion CNY | 28.14% |
| 2015 Q1 | 3.06 Billion CNY | 3.67% |
| 2015 Q3 | 3.41 Billion CNY | 9.26% |
| 2014 Q2 | 2.77 Billion CNY | 4.26% |
| 2014 Q4 | 2.95 Billion CNY | 0.57% |
| 2014 Q3 | 2.93 Billion CNY | 5.91% |
| 2014 Q1 | 2.66 Billion CNY | -1.21% |
| 2014 FY | 2.95 Billion CNY | 9.72% |
| 2013 Q2 | 2.46 Billion CNY | -2.23% |
| 2013 FY | 2.69 Billion CNY | 13.21% |
| 2013 Q4 | 2.69 Billion CNY | 2.46% |
| 2013 Q1 | 2.52 Billion CNY | 6.0% |
| 2013 Q3 | 2.62 Billion CNY | 6.6% |
| 2012 FY | 2.38 Billion CNY | 0.12% |
| 2012 Q4 | 2.38 Billion CNY | -0.07% |
| 2012 Q3 | 2.38 Billion CNY | 3.35% |
| 2012 Q2 | 2.3 Billion CNY | -5.6% |
| 2012 Q1 | 2.44 Billion CNY | 2.68% |
| 2011 FY | 2.37 Billion CNY | 8.74% |
| 2011 Q2 | 2.34 Billion CNY | 5.28% |
| 2011 Q3 | 2.58 Billion CNY | 10.49% |
| 2011 Q4 | 2.37 Billion CNY | -8.17% |
| 2011 Q1 | 2.22 Billion CNY | 1.78% |
| 2010 FY | 2.18 Billion CNY | -2.89% |
| 2010 Q1 | 2.23 Billion CNY | -0.59% |
| 2010 Q2 | 2.2 Billion CNY | -1.35% |
| 2010 Q3 | 2.21 Billion CNY | 0.32% |
| 2010 Q4 | 2.18 Billion CNY | -1.29% |
| 2009 Q4 | 2.25 Billion CNY | -1.53% |
| 2009 Q3 | 2.28 Billion CNY | 0.22% |
| 2009 Q1 | 2.24 Billion CNY | 3.28% |
| 2009 Q2 | 2.28 Billion CNY | 1.73% |
| 2009 FY | 2.25 Billion CNY | 3.69% |
| 2008 FY | 2.17 Billion CNY | -4.31% |
| 2008 Q1 | 2.29 Billion CNY | 1.08% |
| 2008 Q2 | 2.31 Billion CNY | 1.14% |
| 2008 Q3 | 2.2 Billion CNY | -4.79% |
| 2008 Q4 | 2.17 Billion CNY | -1.68% |
| 2007 Q4 | 2.26 Billion CNY | 6.97% |
| 2007 Q2 | 2.09 Billion CNY | 2.09% |
| 2007 FY | 2.26 Billion CNY | 15.35% |
| 2007 Q1 | 2.05 Billion CNY | 4.3% |
| 2007 Q3 | 2.12 Billion CNY | 1.27% |
| 2006 Q3 | 1.96 Billion CNY | -1.46% |
| 2006 Q4 | 1.96 Billion CNY | 0.18% |
| 2006 Q1 | 1.95 Billion CNY | 3.97% |
| 2006 Q2 | 1.99 Billion CNY | 1.67% |
| 2006 FY | 1.96 Billion CNY | 4.36% |
| 2005 Q4 | 1.88 Billion CNY | -1.23% |
| 2005 Q3 | 1.9 Billion CNY | 2.77% |
| 2005 Q2 | 1.85 Billion CNY | 3.09% |
| 2005 Q1 | 1.8 Billion CNY | -0.27% |
| 2005 FY | 1.88 Billion CNY | 4.36% |
| 2004 Q2 | 1.87 Billion CNY | 0.46% |
| 2004 Q3 | 1.87 Billion CNY | 0.21% |
| 2004 Q4 | 1.8 Billion CNY | -3.69% |
| 2004 FY | 1.8 Billion CNY | 0.62% |
| 2004 Q1 | 1.86 Billion CNY | 3.78% |
| 2003 Q2 | 1.64 Billion CNY | 1.0% |
| 2003 Q4 | 1.79 Billion CNY | 8.51% |
| 2003 Q3 | 1.65 Billion CNY | 0.5% |
| 2003 FY | 1.79 Billion CNY | 14.45% |
| 2003 Q1 | 1.62 Billion CNY | 3.9% |
| 2002 Q4 | 1.56 Billion CNY | 1.69% |
| 2002 Q1 | 1.45 Billion CNY | -0.03% |
| 2002 FY | 1.56 Billion CNY | 7.69% |
| 2002 Q3 | 1.54 Billion CNY | 4.22% |
| 2002 Q2 | 1.47 Billion CNY | 1.64% |
| 2001 FY | 1.45 Billion CNY | -0.86% |
| 2001 Q4 | 1.45 Billion CNY | 0.0% |
| 2001 Q2 | 1.42 Billion CNY | 0.0% |
| 2000 Q2 | 1.51 Billion CNY | 0.0% |
| 2000 Q4 | 1.46 Billion CNY | 0.0% |
| 2000 FY | 1.46 Billion CNY | -1.89% |
| 1999 Q2 | 1.47 Billion CNY | 0.0% |
| 1999 FY | 1.49 Billion CNY | 27.04% |
| 1999 Q4 | 1.49 Billion CNY | 0.0% |
| 1998 Q2 | 976.4 Million CNY | 0.0% |
| 1998 FY | 1.17 Billion CNY | 34.71% |
| 1998 Q4 | 1.17 Billion CNY | 0.0% |
| 1997 FY | 875.02 Million CNY | 76.45% |
| 1997 Q4 | 875.02 Million CNY | 0.0% |
| 1997 Q2 | 537.15 Million CNY | 0.0% |
| 1996 Q4 | 495.91 Million CNY | 0.0% |
| 1996 FY | 495.91 Million CNY | 51.44% |
| 1996 Q2 | 438.54 Million CNY | 0.0% |
| 1995 Q4 | 327.47 Million CNY | 0.0% |
| 1995 FY | 327.47 Million CNY | 22.87% |
| 1995 Q2 | 301.03 Million CNY | 0.0% |
| 1994 FY | 266.51 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 82.251% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | 54.501% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | 30.849% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | -136.98% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -257.481% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -2144.188% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | 72.741% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -195.668% |